Sumitomo Mitsui Trust Group Inc. Reduces Stock Holdings in American Healthcare REIT, Inc. $AHR

Sumitomo Mitsui Trust Group Inc. decreased its holdings in American Healthcare REIT, Inc. (NYSE:AHR) by 16.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 272,863 shares of the company’s stock after selling 53,864 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 0.17% of American Healthcare REIT worth $10,025,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Moloney Securities Asset Management LLC purchased a new stake in American Healthcare REIT in the second quarter worth $204,000. Ethic Inc. lifted its stake in American Healthcare REIT by 44.8% in the second quarter. Ethic Inc. now owns 11,022 shares of the company’s stock worth $398,000 after acquiring an additional 3,411 shares during the period. International Assets Investment Management LLC purchased a new stake in American Healthcare REIT in the second quarter worth $269,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in American Healthcare REIT in the second quarter worth $13,215,000. Finally, Turtle Creek Wealth Advisors LLC purchased a new stake in American Healthcare REIT in the second quarter worth $211,000. Hedge funds and other institutional investors own 16.68% of the company’s stock.

Insider Buying and Selling at American Healthcare REIT

In other news, EVP Mark E. Foster sold 3,850 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total transaction of $161,276.50. Following the completion of the transaction, the executive vice president directly owned 59,100 shares in the company, valued at $2,475,699. This trade represents a 6.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.92% of the stock is owned by insiders.

American Healthcare REIT Price Performance

Shares of NYSE:AHR opened at $44.52 on Thursday. American Healthcare REIT, Inc. has a 1-year low of $24.21 and a 1-year high of $45.00. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.48 and a quick ratio of 0.48. The business has a fifty day moving average price of $42.38 and a 200-day moving average price of $38.03. The company has a market capitalization of $7.50 billion, a PE ratio of -202.35, a PEG ratio of 2.20 and a beta of 0.98.

American Healthcare REIT (NYSE:AHR) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.02. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.The firm had revenue of $542.50 million during the quarter, compared to the consensus estimate of $539.49 million. During the same period last year, the company earned $0.33 earnings per share. The company’s revenue was up 7.5% on a year-over-year basis. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. As a group, equities analysts expect that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.

American Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 17th. Stockholders of record on Tuesday, September 30th were issued a dividend of $0.25 per share. The ex-dividend date was Tuesday, September 30th. This represents a $1.00 annualized dividend and a dividend yield of 2.2%. American Healthcare REIT’s dividend payout ratio (DPR) is presently -454.55%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Truist Financial raised their price target on American Healthcare REIT from $44.00 to $46.00 and gave the stock a “buy” rating in a research note on Tuesday, August 26th. Scotiabank reissued an “outperform” rating on shares of American Healthcare REIT in a research report on Thursday, August 28th. Morgan Stanley reissued an “overweight” rating on shares of American Healthcare REIT in a research report on Wednesday, September 3rd. Royal Bank Of Canada raised their price objective on American Healthcare REIT from $39.00 to $45.00 and gave the company an “outperform” rating in a research report on Wednesday, August 13th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of American Healthcare REIT in a research report on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $45.00.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.